18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy

18FluoroDeoxyGlucose-Positron Emission Tomography (PET) in Patients With Melanoma or Non Small Cell Lung Cancer Treated With Immunotherapy

Study the EFS and OS according to 18FDG PET in patients with melanoma or non small cell lung cancer treated by immunotherapy.

Study EFS in patients with melanoma or NSCLC treated by immunotherapy (anti CTLA4 or anti PDL1) and performed18FDG PET

Multicentric retrospective study

Inclusion Criteria:

• patients treated for melanoma or NSCLC with immunotherapy (anti CTLA4 or antiPDL1)
• patients treated in Brest, Morlaix, Landerneau hospital
• patients performed FDG PET
• no opposition to study

Exclusion Criteria:

• age under 18 years old
• refusal to participate